Pharmacovigilance is essential for ensuring medication safety, and the Namibia Medicines Regulatory Council (NMRC) leads these efforts.

Appointed by the Minister of Health, the NMRC is composed of 12 members and focusses on various aspects of drug safety, including clinical evaluations and vaccine-related adverse events.

Reporting adverse drug reactions is crucial, and specific guidelines are in place for both healthcare professionals and manufacturers to ensure comprehensive monitoring and appropriate responses to safety concerns.